A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.
Opella is honoring its commitment to maintaining production volumes, investment levels, and jobs at its French plants by spending €40m to upgrade two sites in the country.
UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.
In announcement of approving VKT Pharma’s application, FDA included storage and handling instructions common in labeling, suggesting concerns persist about the potential for NDMA to form after products are distributed.
Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.
The trophies have been presented at the OTC Marketing Awards 2025 - but what did the judging panel have to say about the winning and highly-commended entries?
Winners across 12 categories were announced at the OTC Marketing Awards 2025 on 20 November, with Opella crowned OTC Company of the Year.
UK development firm Futura Medical is set to raise £2.75m to keep the company operational and provide cash for its R&D plans.
A round-up of the latest European people news: Haleon elects board chair; Bayer names group CFO; Boots adds customer & marketing director.
“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.
Bayer expects Consumer Health sales for the full year to advance by 1% at best due to increasingly challenging conditions in its two largest markets.
EllaOne manufacturer Perrigo tells HBW Insight that Community Pharmacy England's decision to offer free emergency contraception is "the right move for women" but also "makes pharmacy training and sex education more important than ever."
Cipla has paid Tata Industries around $12.5m for Inzpera Healthsciences to grow its consumer health portfolio.
Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.
Dental guards already accounted for “well over half of the brand’s revenue” and DenTek claimed more than 50% of US category share when PCH launched "Fantasy Guards" campaign targeting fantasy football league enthusiasts.
Perrigo pauses $240m spending planned for formula business as it considers options to be in better position to boost growth on OTC drugs. “Problems make formula manufacturing’s “long-term fit alongside our faster-growing, higher-cash-yielding consumer health OTC portfolio less strategic,” says presi
A round-up of the latest European people moves: Stada names new heads for Germany and UK; Orifarm makes board appointment; MHRA fills new chief medical and scientific officer role.
Kenvue share price on downward trend since its highly anticipated spinout from J&J in 2023.
Kenvue’s latest results could be a sign of things to come for other consumer health product businesses launched as spinouts from pharmaceutical giants. Along with its third-quarter results on Nov. 3, Kenvue announces deal to be acquired by Kimberly-Clark.
“Incredible rigor, thoughtfulness and discipline” went into Kleenex tissues, Huggies disposable diapers, and Kotex tampons marketer Kimberly-Clark’s $48.7bn offer for Kenvue, the former J&J consumer health products business on its own for two years.